Prof. Jianxing He’s team at Guangzhou Medical University First Affiliated Hospital has made a historic impact in robotic thoracic surgery. Their clinical research on the world’s first tubeless anatomical lung resection via intercostal single-port robotic approach—using the China-developed SHURUI® system—was published in Annals of Thoracic Surgery and honored with the ESTS Fellowship Award at the 2025 European Society of Thoracic Surgeons (ESTS) Congress.
The study demonstrated 100% success without conversion or additional ports, minimal blood loss, and high postoperative satisfaction, proving the system’s safety and feasibility in complex lung cancer procedures.
Beyond clinical performance, SHURUI® system introduces key engineering innovations: a nickel-titanium snake arm, 3D vision, and multi-channel trocar design—breaking through limitations of traditional robotic platforms.
At ESTS, the team presented a full 8-year research program spanning AI-assisted surgery, autonomous platforms, and surgical quality assessment, marking a major milestone in China's journey from technological imitation to global innovation leadership in intelligent, minimally invasive thoracic surgery.
Important Notes
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.
